Substance / Medication

Peginterferon alfa-2b

Overview

Active Ingredient
peginterferon alfa-2b
RxNorm CUI
253453

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

190 trials linked to this intervention

190
Total Trials
21
Recruiting
76
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy and safety of ropeginterferon alfa-2b in the treatment of polycythemia vera: a systematic review with single arm meta-analysis.
Nada Eman Ayman, Elfagieh Mohamed Abdelhalim, Abdelsalam Fares et al. · Ann Hematol · 2025
PMID: 41238945Meta-AnalysisFull text (PMC)
Neutrophil/lymphocyte ratio identifies low-risk polycythaemia vera patients for early Ropeginterferon alfa-2b therapy.
Barbui Tiziano, Carobbio Alessandra, Guglielmelli Paola et al. · Br J Haematol · 2024
PMID: 39375955RCT
Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C.
Hsu Shih-Jer, Yu Ming-Lung, Su Chien-Wei et al. · J Formos Med Assoc · 2021
PMID: 33077341RCT
Peginterferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomised study.
Papadopoulos Vasileios P, Chrysagis Dimitrios N, Protopapas Andreas N et al. · Med Sci Monit · 2009
PMID: 19179968RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Peginterferon alfa-2b (substance)
SNOMED CT
395823000
UMLS CUI
C0796545
RxNorm CUI
253453

Clinical Data

This intervention maps to 26 entities in the Healos knowledge graph.

20
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
190
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.